Related Experiment Video

Updated: Jul 14, 2026

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1
08:53

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1

Published on: February 17, 2011

Altered expression of the early mitotic checkpoint protein, CHFR, in breast cancers: implications for tumor

Lisa M Privette1, Maria E González, Lei Ding

  • 1Department of Human Genetics, University of Michigan, Ann Arbor, Michigan 48109-0638, USA.

Cancer Research
|June 29, 2007
PubMed

Insights

Checkpoint with FHA and Ring Finger (CHFR) acts as a tumor suppressor in breast cancer. Loss of CHFR expression is linked to aggressive tumor features and promotes malignant progression, highlighting its critical role.

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Cancer Research

Background:

  • Checkpoint with FHA and Ring Finger (CHFR) is a cell cycle regulator involved in mitotic checkpoint control.
  • Evidence suggests CHFR functions as a tumor suppressor, with its expression often lost in various cancers.
  • Loss of CHFR expression can be attributed to mechanisms like promoter hypermethylation.

Purpose of the Study:

  • To investigate the role of CHFR as a tumor suppressor in breast cancer.
  • To determine the association between CHFR expression and clinical-pathological variables in breast cancer patients.
  • To elucidate the functional consequences of CHFR loss in breast cancer progression.

Main Methods:

  • Analysis of CHFR protein expression in breast cancer cell lines and primary patient samples.
  • Correlation of CHFR expression levels with clinical and pathological data.
  • In vitro studies using RNA interference to deplete CHFR in immortalized human mammary epithelial cells.

Main Results:

  • Reduced or absent CHFR protein expression was observed in 41% of cell lines and 36% of patient samples.
  • Lack of CHFR expression correlated with larger tumor size and was weakly associated with estrogen receptor-negative status.
  • In vitro depletion of CHFR led to phenotypes indicative of malignant progression, including increased growth, invasiveness, motility, aneuploidy, and anchorage-independent growth.

Conclusions:

  • CHFR is a relevant tumor suppressor in breast cancer.
  • Loss of CHFR expression is associated with adverse clinicopathological features and promotes malignant phenotypes.
  • CHFR warrants further investigation as a potential therapeutic target in breast cancer treatment.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...